Dimensional Fund Advisors LP Raises Holdings in The Cooper Companies, Inc. $COO

Key Points

• Dimensional Fund Advisors LP increased its stake in The Cooper Companies, Inc. by 4.1% in the first quarter, acquiring an additional 63,681 shares, bringing its total to approximately 1.62 million shares valued at $136.79 million.
• Recent analyst ratings show a mixed outlook for COO, with one Strong Buy, nine Buy, and two Hold ratings, leading to an average rating of "Moderate Buy" and a consensus target price of $96.73.
• Cooper Companies reported earnings that beat estimates with a $0.96 EPS for the last quarter and has set a FY 2025 EPS guidance of 4.050-4.110.

Dimensional Fund Advisors LP grew its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,621,839 shares of the medical device company's stock after purchasing an additional 63,681 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.81% of Cooper Companies worth $136,793,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Shell Asset Management Co. increased its position in shares of Cooper Companies by 15.5% during the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after purchasing an additional 127 shares in the last quarter. UMB Bank n.a. increased its position in shares of Cooper Companies by 16.7% during the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after purchasing an additional 129 shares in the last quarter. Horizon Investments LLC increased its position in shares of Cooper Companies by 5.0% during the first quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock worth $241,000 after purchasing an additional 136 shares in the last quarter. Axxcess Wealth Management LLC increased its position in shares of Cooper Companies by 1.9% during the first quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after purchasing an additional 140 shares in the last quarter. Finally, Mitchell & Pahl Private Wealth LLC increased its position in shares of Cooper Companies by 1.8% during the first quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock worth $732,000 after purchasing an additional 157 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Trading Up 3.0%

Shares of Cooper Companies stock traded up $2.18 during trading hours on Friday, hitting $75.22. The company's stock had a trading volume of 1,992,159 shares, compared to its average volume of 1,562,351. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38. The firm has a fifty day moving average of $72.18 and a 200-day moving average of $78.20. The stock has a market cap of $15.04 billion, a price-to-earnings ratio of 36.51, a P/E/G ratio of 1.84 and a beta of 1.00. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.The business had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same quarter in the prior year, the company posted $0.85 EPS. The company's quarterly revenue was up 6.3% on a year-over-year basis. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on COO. Piper Sandler restated an "overweight" rating and issued a $105.00 target price (down from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Wells Fargo & Company dropped their target price on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a report on Friday, May 30th. Mizuho dropped their target price on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a report on Wednesday, July 16th. Needham & Company LLC upgraded Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price for the company in a report on Tuesday, June 17th. Finally, Loop Capital set a $100.00 target price on Cooper Companies in a report on Tuesday, June 17th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $96.73.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.